Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Colloca A"'
Publikováno v:
Clinical Oncology. 28:e155-e164
Aims Progression-free survival is recognised as an appropriate end point for randomised clinical trials of chemotherapy of patients with metastatic colorectal cancer, although it is not clear if it is reliable after chemotherapy plus bevacizumab. Mat